FDA approves variance for sale of KODAK Systems using KODAK Laser Projection Technology

NewsGuard 100/100 Score

The Food and Drug Administration (FDA) has approved a variance that allows for the sale of KODAK Laser Projector Systems using KODAK Laser Projection Technology to cinema exhibitors without the need for individual site or show operator variances. This is an important step forward in delivering brighter 2D and 3D images that provide higher dynamic range and a wider color gamut to theaters.

“We at Kodak have always endeavored to provide filmmakers with the best possible tools with which to tell their stories. That philosophy has served us well for more than a century, and we will continue nurturing that partnership long into the future.”

"The FDA approval brings KODAK Laser Projection Technology significantly closer to the marketplace and validates the work we've done to ensure that this technology is safe and dependable," says Les Moore, Kodak's chief operating officer for Digital Cinema. "In addition to allowing the sale of KODAK Laser Projector Systems using KODAK Laser Projection Technology, the FDA variance serves as a template to be followed by manufacturers that we license to incorporate this new laser technology."

Typically, digital projection systems using high power lasers fall under the definition of a "demonstration laser" and must follow existing regulations for conventional laser projectors, such as those used in laser light show displays. Kodak has been working in conjunction with laser safety consultants and the FDA to address potential safety issues. The unique optical design of KODAK Laser Projection Technology manages the projector output so that it can be considered to be similar to conventional Xenon projection systems. The FDA variance allows the sale of KODAK Laser Projector Systems with KODAK Laser Projection Technology and theater/show configurations incorporating them.

KODAK Laser Projection Technology promises to bring vastly improved image quality to theater screens, including significantly brighter 3D viewing, and to dramatically reduce costs to digital projection in cinemas through the innovative use of long-life lasers, lower-cost optics, and more efficient energy usage. Kodak introduced its laser technology in September 2010. The technology has been received enthusiastically by exhibitors, manufacturers, studios, and viewers who have seen the demonstrations.

Moore notes that KODAK Laser Projection Technology is a key ingredient to potential improvements in digital cinema picture quality for both filmmakers and movie-goers. "This laser technology is a significant breakthrough that promises to have a positive ripple effect throughout the cinema world," adds Moore. "We at Kodak have always endeavored to provide filmmakers with the best possible tools with which to tell their stories. That philosophy has served us well for more than a century, and we will continue nurturing that partnership long into the future."

Kodak is in discussions to license this advanced technology, with an eye toward marketplace implementation within the next two years.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates